Back to User profile » Prof. Dr. Jürgen Behr
Papers published by Prof. Dr. Jürgen Behr:
Domestic Parasitic Infections in Patients with Asthma and Eosinophilia in Germany – Three Cases with Learnings in the Era of Anti- IL5 Treatments
Barnikel M, Grabmaier U, Mertsch P, Ceelen F, Janke C, Behr J, Kneidinger N, Milger K
Journal of Asthma and Allergy 2023, 16:1229-1232
Published Date: 9 November 2023
Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET
Fischer C, Jörres RA, Alter P, Trudzinski FC, Yildirim, Bals R, Vogelmeier CF, Kauffmann-Guerrero D, Behr J, Watz H, Holle R, Kahnert K
Patient Preference and Adherence 2022, 16:1759-1770
Published Date: 26 July 2022
Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
Kahnert K, Jörres RA, Lucke T, Trudzinski FC, Mertsch P, Bickert C, Ficker JH, Behr J, Bals R, Watz H, Welte T, Vogelmeier CF, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3189-3199
Published Date: 24 November 2021
Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months
Kayser MZ, Drick N, Milger K, Fuge J, Kneidinger N, Korn S, Buhl R, Behr J, Welte T, Suhling H
Journal of Asthma and Allergy 2021, 14:863-871
Published Date: 12 July 2021
Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
Lutter JI, Jörres RA, Trudzinski FC, Alter P, Kellerer C, Watz H, Welte T, Bals R, Kauffmann-Guerrero D, Behr J, Holle R, Vogelmeier CF, Kahnert K
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:987-998
Published Date: 14 April 2021
Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma
Drick N, Milger K, Seeliger B, Fuge J, Korn S, Buhl R, Schuhmann M, Herth F, Kendziora B, Behr J, Kneidinger N, Bergmann KC, Taube C, Welte T, Suhling H
Journal of Asthma and Allergy 2020, 13:605-614
Published Date: 11 November 2020
Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort
Lutter JI, Jörres RA, Welte T, Watz H, Waschki B, Alter P, Trudzinski FC, Ohlander J, Behr J, Bals R, Studnicka M, Holle R, Vogelmeier CF, Kahnert K
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2787-2798
Published Date: 5 November 2020
Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort
Königsdorfer N, Jörres RA, Söhler S, Welte T, Behr J, Ficker JH, Bals R, Watz H, Lutter JI, Lucke T, Biertz F, Alter P, Vogelmeier CF, Kahnert K
Patient Preference and Adherence 2019, 13:1711-1721
Published Date: 10 October 2019
Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism
Milger K, Holdt LM, Teupser D, Huber RM, Behr J, Kneidinger N
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:891-897
Published Date: 7 May 2015